WuXi PharmaTech laboratory testing division expands in U.S. with acquisition of XenoBiotic Laboratories

摘要

WuXi PharmaTech Inc. (WuXi), a leading pharmaceutical, biotechnology, and medical device research and development outsourcing company with operations in China and the United States, has acquired XenoBiotic Laboratories, Inc. (XBL), a contract research organization with 27 years of successful operation that provides bioanalytical, drug metabolism, and pharmacokinetic services to the pharmaceutical, animal health, and agrochemical industries.